A randomized, double-blind, placebo-controlled, Phase I/II trial of RNActive(®)-vaccine cv9104 in patients with metastatic castrate-refractory prostate cancer (mcrpc): first result...

por Koch, Sven D, Hong, Henoch, Feyerabend, Susan, Retz, Margitta, Kuebler, Hubert, Heidenreich, Axel, van Erps, Thomas, Schroeder, Andreas, Scheel, Birgit, Reus, Valérie, Kallen, Karl-Josef, Fotin-Mleczek, Mariola, Gnad-Vogt, Ulrike, Stenzl, Arnulf
Publicado 2014